Breaking Finance News

Goldman Sachs disclosed Mead Johnson Nutrition Company (NYSE:MJN), bumping down its price target to $85.00 earlier today

Reporting a potential upside of 0.11%, Goldman Sachs dropped the price target of Mead Johnson Nutrition Company (NYSE:MJN) to $85.00

On 9/8/2016, Citigroup released a statement about Mead Johnson Nutrition Company (NYSE:MJN) dropped the target price from $106.00 to $103.00 that suggested an upside of 0.29%.

Having a price of $76.90, Mead Johnson Nutrition Company (NYSE:MJN) traded -1.85% lower on the day. With the last stock price down -9.38% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same period. MJN has recorded a 50-day average of $82.73 and a two hundred day average of $84.86. Trade Volume was down over the average, with 982,090 shares of MJN changing hands under the typical 1,392,470

Recent Performance Chart

Mead Johnson Nutrition Company (NYSE:MJN)

Mead Johnson Nutrition Company has PE ratio of 28.93 with a one year low of $65.53 and a one year high of $94.40 and has a market capitalization of $0.

A total of 12 brokerages have released a report on Mead Johnson Nutrition Company. zero brokerages rating the company a strong buy, zero brokerages rating the company a buy, zero brokerages rating the company a hold, zero brokerages rating the company a underperform, and finally zero brokerages rating the company a sell with a 12-month price target of $82.00.

General Company Details For Mead Johnson Nutrition Company (NYSE:MJN)

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children's milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company's Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children, and expectant and nursing mothers. The Company markets its portfolio of approximately 70 products to mothers, healthcare professionals and retailers in over 50 countries in Asia, North America, Latin America and Europe.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *